In the present study, using two different mouse models of experimental arthritis, we addressed the role of the CD39/CD73 adenosinergic pathway and the contribution of the A2aR to the anti-inflammatory effects of exogenous treatment with FBP. This evidence concerns the gene NT5E and Arthritis.